[Accountability of anti-cholinergic drugs in increase of psychotic episodes: A case of tropatepine overdose].

Imputabilité des traitements anticholinergiques dans l’exacerbation d’épisodes psychotiques : à propos d’un cas de surdosage en tropatépine.
Anticholinergic Anticholinergique Drug poisoning Iatrogenic medications Iatrogénie médicamenteuse Intoxication médicamenteuse Psychotic episode Tropatepine Tropatépine Épisode psychotique

Journal

La Revue de medecine interne
ISSN: 1768-3122
Titre abrégé: Rev Med Interne
Pays: France
ID NLM: 8101383

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 17 01 2020
revised: 31 07 2020
accepted: 29 08 2020
pubmed: 11 11 2020
medline: 25 11 2021
entrez: 10 11 2020
Statut: ppublish

Résumé

Corrective treatments for some neurological side effects due to antipsychotic treatments can induce anticholinergic adverse effects. However, the risk of triggering or increasing psychotic symptoms induced by these drugs is unknown with only one case-report concerning the tropatepine. In addition, recommendations for the use of these drugs remain imprecise regarding the management of this type of adverse effect. We report the case of a psychotic episode in an 18-year-old patient potentially acutised after an auto-intoxication with tropatepine. At high doses, anticholinergic treatments, including tropatepine, might increase psychotic episodes. In addition, the available epidemiological data reveal an inappropriate and excessive prescription of these drugs. Their use and risks should be better known and need an update of the available recommendations.

Identifiants

pubmed: 33168356
pii: S0248-8663(20)30364-7
doi: 10.1016/j.revmed.2020.08.015
pii:
doi:

Substances chimiques

Cholinergic Antagonists 0
Dibenzothiepins 0
Pharmaceutical Preparations 0
tropatepine C27HY5RFU5

Types de publication

Case Reports Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

127-130

Informations de copyright

Copyright © 2020 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

C Jaussaud (C)

Service de psychiatrie, CHU de Caen, centre Esquirol, 14000 Caen, France.

P Lebain (P)

Service de psychiatrie, CHU de Caen, centre Esquirol, 14000 Caen, France.

L Tessiot (L)

Service de psychiatrie, CHU de Caen, centre Esquirol, 14000 Caen, France.

S Dollfus (S)

Service de psychiatrie, CHU de Caen, centre Esquirol, 14000 Caen, France; Normandie université, UNICAEN, ISTS, EA 7466, 14000 Caen, France.

J Madigand (J)

Service de psychiatrie de l'enfant et de l'adolescent, CHU de Caen, 14, avenue Clemenceau, CS 30001, 14033 Caen cedex 9, France; Fondation FondaMental, Créteil, France. Electronic address: madigand-j@chu-caen.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH